This article explores the lessons learned during the implementation of a peer-facilitated hepatitis C virus hepatitis C testing and treatment access project called the Live Hep C Free project in contributing to micro-elimination efforts...
People who inject drugs (PWID) are a key population for the elimination of hepatitis C in Europe, and increasing their access to HCV testing and care is a goal in European and national hepatitis C policies. Despite this, HCV testing remains...
This manual provides a step-by-step guide for those involved in planning and managing infectious diseases and drug services, focusing on how to identify barriers to and opportunities for improving provision of HCV testing and access to treatment for people who use drugs.
Eliminating hepatitis C in prisons will be a crucial setting if World Health Organization (WHO) elimination targets are to be achieved. For World Hepatitis Day, we’ll hear from experts about the evidence that
Abstract Background: The impact of Hepatitis C virus (HCV) RNA levels on the evolution of chronic HCV infection-related liver damage is controversial. Heavy alcohol use is believed to have a deleterious impact on the course of HCV disease...
Summary: This knowledge questionnaire has been developed by the EMCDDA as part of its initiative to increase access to hepatitis C care through drug services. The main aims of the knowledge questionnaire are: to refresh knowledge on...
The opioid epidemic has resulted in significant increases in Hepatitis C Virus (HCV) among people who inject drugs, accounting for 23% of new infections. HCV is completely curable and testing and treatment are the path to cure. Opioid...